Introduction: Pretreatment mutations (such as
T38A,
Y124H,
D134E,
N139K/H,
I224V, and
R242A) were defined as amino acid substitutions that have been reported among NA-naive patients but their relationships with antiviral resistance development have not been clarified yet.